Suppr超能文献

洛哌丁胺:通过阻断钙通道发挥止泻作用的机制

Loperamide: blockade of calcium channels as a mechanism for antidiarrheal effects.

作者信息

Reynolds I J, Gould R J, Snyder S H

出版信息

J Pharmacol Exp Ther. 1984 Dec;231(3):628-32.

PMID:6502516
Abstract

The antidiarrheal opiates loperamide, fluperamide, diphenoxylate and fetoxylate inhibited binding of [3H]nitrendipine to membranes from guinea-pig cerebral cortex with Ki values of 0.5 to 10 microM. Loperamide and fluperamide reversed the tiapamil elicited lowering of [3H]nitrendipine binding with IC50 values of 0.2 to 0.5 microM, indicating a verapamil-like action of these drugs. An oral dose of 1 mg/kg of loperamide reduced gastrointestinal motility and gave concentrations of 0.45 +/- 0.19, 0.38 +/- 0.22 and 0.49 +/- 0.25 microM in the duodenum, jejunum and ileum, respectively. The apparent Ki for loperamide in preventing calcium-induced contractions of guinea-pig ileum depolarized with 80 mM potassium was 0.10 microM. We propose that calcium channel antagonism is responsible at least in part for the antidiarrheal actions of loperamide and related agents. Evidence includes the calcium antagonist actions of loperamide at antidiarrheal doses, the constipating effects of certain calcium antagonists and the failure of opiate antagonists to prevent some intestinal effects of loperamide.

摘要

止泻性阿片类药物洛哌丁胺、氟哌酰胺、地芬诺酯和非托酯抑制了[3H]尼群地平与豚鼠大脑皮层膜的结合,其Ki值为0.5至10微摩尔。洛哌丁胺和氟哌酰胺逆转了替帕米引起的[3H]尼群地平结合降低,IC50值为0.2至0.5微摩尔,表明这些药物具有维拉帕米样作用。口服1毫克/千克的洛哌丁胺可降低胃肠蠕动,在十二指肠、空肠和回肠中的浓度分别为0.45±0.19、0.38±0.22和0.49±0.25微摩尔。洛哌丁胺在预防用80毫摩尔钾去极化的豚鼠回肠钙诱导收缩中的表观Ki为0.10微摩尔。我们提出钙通道拮抗作用至少部分地是洛哌丁胺及相关药物止泻作用的原因。证据包括洛哌丁胺在止泻剂量下的钙拮抗剂作用、某些钙拮抗剂的便秘作用以及阿片拮抗剂未能预防洛哌丁胺的一些肠道作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验